Skip to content
stockmarketcap
Discover
Top gainersTop losersMost activeMarket sectorsHeatmapTreasury rates
Earnings calendarIPO calendarEx-dividend calendarEconomic calendar
Congress tradesInsider tradesAnalyst upgrades & downgrades
Collections
ScreenerCompareBacktester
ValuationFundamentals
WatchlistPortfolioPricing
Sign in
Markets
StocksGainersLosersMost activeMarket sectorsHeatmapEarnings calendarCongress tradesInsider tradesAnalyst upgrades/downgradesIPO calendarEx-dividend calendar
Tools
ScreenerCompare stocksReturns backtesterPortfolio trackerWatchlistEmbeddable widget
Metrics
ValuationFundamentals
Popular lists
Best dividend stocksBest value stocksLargest companiesLowest P/E stocks
Collections
All lists & collectionsUS stocksJapanese stocksChinese stocksHong Kong stocksSouth Korean stocksTaiwanese stocksCanadian stocksUK stocksEuropean stocksMagnificent 7AI stocksSemiconductor stocks
Compare
Compare stocksFinviz alternativeKoyfin alternativeTradingView alternativeStockAnalysis alternative
Learn
Investing glossaryHelp & guide
StockMarketCapDocsTokenTermsPrivacyData for information only, not investment advice.
◆

LLY vs ABBV

Eli Lilly and Company and AbbVie Inc. compared side by side. Customize this comparison

Performance (normalized)

-8%+100%+207%+315%+422%stockmarketcap.io

Key metrics

MetricLLY logoLLYABBV logoABBV
Price$1,210.50$261.07
Market cap$1.14T$461.26B
P/E ratio (TTM)42.53x123.28x
P/S ratio (TTM)15.63x7.07x
Dividend yield0.54%2.68%
Beta0.520.31
1-year return+55.77%+36.87%

Want return correlation and up to five stocks side by side? The advanced compare tool is part of Plus.